comparemela.com

Latest Breaking News On - Katherine kahn - Page 1 : comparemela.com

Rifaximin Prophylaxis Fails for Bacterial Peritonitis in Cirrhotic Patients

'Is it time to say primary prophylaxis is dead?' one expert asks

Jasmohan bajajKatherine kahnRichmond va medical centerVirginia commonwealth universityCentre hospitalierEuropean associationEnd stage liver diseaseAmerican associationMedpage today

Testosterone Prodrug Improves Muscle Mass, Encephalopathy in Men With Cirrhosis

Androgen precursor may help cirrhosis-related sarcopenia

Katherine kahnWorth pursuingEnd stage liver diseaseMedpage today

Weight Loss/Diabetes Drug Has Positive Treatment Effect on MASH

GLP-1/GIP agonist also improved fibrosis biomarkers, liver fat, and stiffness in phase II trial

Eli lillyLoombar tirzepatideKatherine kahnNew england journalMedpage todayEngland journalEnglj med

Patients With Severe ACLF on Liver Transplant Waitlists Face High Mortality Rates

Urgent need for organ allocation system reform, researchers say

United statesW ray kimKatherine kahnAsia pauthorHeiner wedemeyerStanford health careChronic liver failure consortiumHannover medical school in hanoverModel for end stage liver diseaseLatin americaHannover medical schoolAmerican associationLiver diseasesNorth americaMedpage today

Novel Glucagon/GLP-1 Receptor Dual Agonist Improved MASH in Phase II Study

Effects may be related to weight loss, not changes in fibrogenesis, expert suggests

Katherine kahnNew england journalMedpage todayEngland journalEnglj med

vimarsana © 2020. All Rights Reserved.